3[1]Hollstein M, Sidransky D, Vagelstein B, et al. p53 mutations in human cancers. Science, 1991, 253:49～53
4[2]Sozzi G, Camey D. Molecular biology of lung cancer. Curr Opin Pulm Mod, 1998, 4(4): 207～212
5[3]Soussi T, Legros Y, Lubin R, et al. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer,1994, 57:1～9
6[4]Brambilla E,Brambilla C. p53 and lung cancer. Pathol Biol,1997, 45(10): 852～863
7[5]Lubin R, Schlichtholz B, Teillaud JL, et al. p53 antibodies in patients with various types of cancer assay, identification and characterization. Clin Cancer Res, 1995, 1:1463～1469
8[6]Soussi T. p53 antibodies in the sera of patients with various type of cancer: a review. Cancer Res, 2000,60:1777～1788
9[7]Lenner P, Wiklund F, Emdin SO, et al. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study. Br J Cancer,1999, 79(5～6): 927～932
10[8]Laudanski J, Burzykowski T, Niklinska W, et al. Prognostic value of serum p53 antibodies in patients with resected nonsmall cell lung cancer. Lung Cancer, 1998, 22:191～200
